AzTrials
AzTrials

Clinical PainPBAMNCT02240303

Pain, Brain and Mobility Study

An observational study of Clinical Pain and Brain and Mobility Changes, run by University of Florida.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

The aim of this project will be to document the central and peripheral mechanisms, which may predict clinical pain characteristics and associated physical performance in older adults. Read more about this study

Who is it for?
Ages 65 years and olderHealthy volunteers can take part
Conditions the study is for
Clinical Pain, Brain and Mobility Changes
What is being tested?
Quantitative Sensory Testing (QST), Physical Performance and Magnetic Resonance Imaging (MRI)
Type of treatment
Surgery or procedure
How many people
0 participants
Where
No sites listed yet
Study dates
Apr 2015to Apr 2015
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Study population: Older adults

Who may be able to join

  • Age 65 years and older
  • Willingness to participate in all study procedures
  • Cognitively intact as defined by 3MS score > 80

Who cannot join

  • Failure to provide informed consent;
  • Contraindications to MRI, such as claustrophobia, heart pacemaker / defibrillator, heart valve prosthesis, aneurysm clip, metallic stent, neurostimulation system, cochlear implants or inner ear prosthesis, insulin pump or other infusion pump, metal slivers in the orbital area/eye socket
  • Active treatment for cancer or history of cancer in the past year
  • Severe cardiac disease, including New York Heart Association (NYHA) Class III or IV congestive heart failure, clinically significant aortic stenosis, history of cardiac arrest or stroke, use of a cardiac defibrillator, or uncontrolled angina;
  • Previous stroke with upper and/or lower extremities involvement within the last 6 months
  • History of life-threatening cardiac arrhythmias, stroke, severe Parkinson's disease or severe neurological disorders likely to interfere with physical function
Show all 20Show fewer
  • Renal disease requiring dialysis
  • Lung disease requiring steroids
  • Inability to reliably rate pain intensity
  • Current use of tobacco products
  • Uncontrolled hypertension (BP of greater than 150/99 mm Hg)
  • Serious systemic disease that restrict normal daily activities
  • Neurological problems with significant changes in somatosensory and pain perception at the intended stimulation sites,
  • Uncontrolled psychiatric condition (e.g., experiencing symptoms of schizophrenia, bipolar disorder, etc.) or hospitalization within the preceding year for psychiatric illness
  • Daily use of narcotic medication
  • Lower extremity amputation
  • Uncontrolled diabetes (self-reported medication use and/or HA1C value)
  • A known diagnosis of dementia
  • Inability to communicate because of severe hearing loss or speech disorder;
  • Severe visual impairment, which would preclude completion of the assessments and/or intervention.

About this study

Official title: Central and Peripheral Mechanisms Predicting Clinical Pain and Physical Performance in Older Adults

The aim of this project will be to document the central and peripheral mechanisms, which may predict clinical pain characteristics and associated physical performance in older adults. Although chronic pain is common among older adults, there is limited understanding on the processing of pain and the mechanisms by which it affects physical function in these individuals. The first aim of this study will be to examine predictors of clinical pain in older adults. These will include a comprehensive somatosensory assessment battery including mechanical and thermal detection and pain thresholds in older adults with and without chronic pain. The investigators will also assess basal cognitive and physical function to determine their associations with chronic pain. Finally, brain structure and function will be assessed in these older adults with and without pain.

Read the detailed description

The purpose of this research study is to learn more about how pain in older individuals changes the brain and impacts a person's mobility and function. Pain is influenced by biology (like hormones), psychology (thoughts and feelings), and habits (like sleep or exercise) that may make older adults more likely to have higher or lower levels of pain.

Being tested
Quantitative Sensory Testing (QST), Physical Performance, Magnetic Resonance Imaging (MRI), Blood Sample
Keywords
pain, mobility, brain, cognition
Medical subject headings
Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Quantitative Sensory Testing (QST)Procedure or surgery

    Participants in both groups will have a sensory assessment called quantitative sensory testing or QST that will assess in detail your ability to feel sensations due to touch, vibration, and changes in temperature on the skin.

  • Physical PerformanceProcedure or surgery

    Participants in both groups will have a Physical Performance test.

  • Magnetic Resonance Imaging (MRI)Procedure or surgery

    Participants in both groups will have an magnetic resonance imaging (MRI).

  • Blood SampleProcedure or surgery

    Participants in both groups will have blood samples taken.

Study groups in NCT02240303
Study groupRoleWhat they receive
Chronic Pain GroupParticipants that experience chronic pain will have the following procedures performed: A sensory assessment called quantitative sensory testing or QST that will assess in detail your ability to feel sensations due to touch, vibration, and changes in temperature on the skin; Pressure sense will be produced by a device that will be pressed against the skin for several seconds; Pinprick pressure will be applied to determine if the pain can be rated; a Physical Performance test will be performed; and an magnetic resonance imaging (MRI) will be done. In addition, blood sample, blood pressure, heart rate, and skin temperature will be taken during the procedures.
Receives: Procedure: Quantitative Sensory Testing (QST); Procedure: Physical Performance; Procedure: Magnetic Resonance Imaging (MRI); Procedure: Blood Sample
No Chronic Pain GroupParticipants that do not experience chronic pain will have the following procedures performed: A sensory assessment called quantitative sensory testing or QST that will assess in detail your ability to feel sensations due to touch, vibration, and changes in temperature on the skin; Pressure sense will be produced by a device that will be pressed against the skin for several seconds; Pinprick pressure will be applied to determine if the pain can be rated; a Physical Performance test will be performed; and an magnetic resonance imaging (MRI) will be done. In addition, blood sample, blood pressure, heart rate, and skin temperature will be taken during the procedures.
Receives: Procedure: Quantitative Sensory Testing (QST); Procedure: Physical Performance; Procedure: Magnetic Resonance Imaging (MRI); Procedure: Blood Sample

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Brain magnetic resonance imaging (MRI)

    Differences in the MRI on the brain scans of participants with greater pain severity

    Measured: Baseline and 12 months later

Secondary outcomes (1)
  1. Inflammatory markers in blood samples

    To test the markers of pro-inflammatory (IL-1b, tumor necrosis factor (TNF-a)) and anti-inflammatory (IL-4, IL-10) with participants more sensitive to pain than the ones less sensitive to pain.

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Sep 2014 (estimated)
  2. Study startApr 2015
  3. Primary completionApr 2015
  4. Study completionApr 2015

Why it stopped: Consolidated study with another protocol

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Time perspective
Prospective
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02240303
Sponsor's protocol ID
201400471
Acronym
PBAM
Status last verified
Feb 2016
First submitted
2 Sep 2014
Last updated
18 Feb 2016
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Clinical Pain and Brain and Mobility Changes, run by University of Florida.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 20 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 18 Feb 2016. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Brain magnetic resonance imaging (MRI) (time frame: Baseline and 12 months later). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Feb 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in